Skip to content

Hyper-ERAS Program for Highly Selective Colorectal Cancer Patients

Hyper Enhanced Recovery After Surgery (Hyper-ERAS) Program for Highly Selective Colorectal Cancer Patients Undergoing Laparoscopic Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06256315
Enrollment
160
Registered
2024-02-13
Start date
2023-06-01
Completion date
2025-08-01
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, ERAS

Keywords

Colorectal Cancer, Hyper-ERAS, Super Accelerated Rehabilitation Surgery, Rapid Rehabilitation, Perioperative Management, ERAS2.0

Brief summary

This clinical trial aims to explore the safety and effectiveness of the Hyper-ERAS rehabilitation protocol for colorectal cancer patients and the feasibility of discharge within 48 hours.

Detailed description

The Hype-ERAS protocol includes preoperative education, intraoperative quality control, postoperative preventive analgesia, early ambulation, early recovery of diet, early removal of drainage tube, urinary catheter, and gastric tube, discharge within 48 hours after surgery, and standardized follow-up outside the hospital. Patients treated with the Hyper-ERAS rehabilitation protocol and discharged within 48 hours were in group A. Patients who were treated with Hyper-ERAS protocol and had a postoperative hospital stay of more than 48 hours were classified as group B. Patients eligible but not treated with the Hyper-ERAS rehabilitation protocol during the same period were in group C (Control group). The postoperative recovery of each group was compared to explore the safety and efficacy of Hyper-ERAS rehabilitation program in patients with colorectal cancer.

Interventions

PROCEDUREHyper-ERAS Program

Patients who met the inclusion criteria were treated with Hype-ERAS protocol, including preoperative education, intraoperative quality control, postoperative preventive analgesia, early ambulation, early recovery of diet, early removal of the drainage tube, urinary catheter, and gastric tube, and discharge within 48 hours or more than 48 hours safter surgery, and closely and standardized follow-up outside the hospital.

Sponsors

Peking University Cancer Hospital & Institute
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

1. Pathologically confirmed colorectal cancer. 2. The position of the anastomosis is above the peritoneal reflection. 3. Age range from 18 to 79 years old. 4. No surgical contraindications. 5. The patient has good compliance and can understand the concept of rapid recovery. 6. Possess basic nursing conditions outside the hospital, and can arrive at the hospital within 30 minutes after discharge.

Exclusion criteria

* The

Design outcomes

Primary

MeasureTime frameDescription
30-day overall complication rate30 days after surgeryThe primary endpoint was the 30-day overall complication rate.

Secondary

MeasureTime frameDescription
Severe complications (CD≥IIIb) rate, within 30 days after surgery30 days after surgerySevere complications (CD≥IIIb) rate
The rehospitalization rate within 30 days after surgery30 days after surgery

Countries

China

Contacts

Primary ContactChanglong Li
vip2nd@163.com+861088196086
Backup ContactLin Wang, M.D.
wanglinmd@foxmail.com+8613910975011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026